Acetylcholinesterase Inhibitors: Structure Based Design, Synthesis, Pharmacophore Modeling, and Virtual Screening

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Chemical Information and Modeling

• Publication date

  2013-08-05

• Fields of study

  Medicine, Chemistry, Computer Science

• Identifiers
  DOI 10.1021/ci400196zPMID 23777291
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Microwave-Assisted and Iodine-Catalyzed Synthesis of Dihydropyrimidin-2-thiones via Biginelli Reaction Under Solvent-Free Conditions

  2013cited by this paper
• Structure‐Based Design and Synthesis of Benzothiazole Phosphonate Analogues with Inhibitors of Human ABAD‐Aβ for Treatment of Alzheimer’s Disease

  2013cited by this paper
• Novel coumarin derivatives bearing N-benzyl pyridinium moiety: potent and dual binding site acetylcholinesterase inhibitors.

  2012cited by this paper
• Models for predicting blood-brain barrier permeation.

  2011cited by this paper
• Microtubule Affinity Regulating Kinase Activity in Living Neurons Was Examined by a Genetically Encoded Fluorescence Resonance Energy Transfer/Fluorescence Lifetime Imaging-based Biosensor

  2011cited by this paper
• Design, synthesis, and evaluation of a novel dual FMS-like tyrosine kinase 3/stem cell factor receptor (FLT3/c-KIT) inhibitor for the treatment of acute myelogenous leukemia.

  2011cited by this paper
• Treatment of Visual Hallucinations in Schizophrenia by Acetylcholinesterase Inhibitors: a case report

  2011cited by this paper
• Rhodanine and thiohydantoin derivatives for detecting tau pathology in Alzheimer's brains.

  2011cited by this paper
• Development and validation of a yeast high-throughput screen for inhibitors of Aβ42 oligomerization

  2011cited by this paper
• Synthesis and insecticidal activity of novel carbamate derivatives as potential dual-binding site acetylcholinesterase inhibitors.

  2010cited by this paper
• Piperazinyl pyrimidine derivatives as potent gamma-secretase modulators.

  2010cited by this paper
• Surface-induced phase separation of a sphingomyelin/cholesterol/ganglioside GM1-planar bilayer on mica surfaces and microdomain molecular conformation that accelerates Abeta oligomerization.

  2010cited by this paper
• Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease

  2009cited by this paper
• Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice.

  2009cited by this paper
• The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics

  2009cited by this paper
• QSAR model for alignment‐free prediction of human breast cancer biomarkers based on electrostatic potentials of protein pseudofolding HP‐lattice networks

  2008cited by this paper
• Molecular modeling of histamine H3 receptor and QSAR studies on arylbenzofuran derived H3 antagonists.

  2008cited by this paper
• Medicinal chemistry and the molecular operating environment (MOE): application of QSAR and molecular docking to drug discovery.

  2008cited by this paper
• Mercury CSD 2.0 – new features for the visualization and investigation of crystal structures

  2008cited by this paper
• When conjugated polymers meet amyloid fibrils.

  2007cited by this paper
• Cholinesterase inhibitors for Alzheimer's disease.

  2006cited by this paper
• Acetylcholinesterase inhibitors for Alzheimer's disease: anti-inflammatories in acetylcholine clothing!

  2006cited by this paper
• Identification of small-molecule inhibitors of the Abeta-ABAD interaction.

  2006cited by this paper
• A preclinical view of cholinesterase inhibitors in neuroprotection: do they provide more than symptomatic benefits in Alzheimer's disease?

  2005cited by this paper
• Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period

  2005cited by this paper
• Propidium-based polyamine ligands as potent inhibitors of acetylcholinesterase and acetylcholinesterase-induced amyloid-beta aggregation.

  2005cited by this paper
• GSK-3 inhibitors and their potential in the treatment of Alzheimer’s disease

  2005cited by this paper
• The Synthesis of Conformationally Constrained Peptides and Pseudo-Peptides Incorporating an Endo-(2S,3R)-2-Amino-3-Carboxy-Norborn-5-ene Residue

  2004cited by this paper
• Acetylcholinesterase inhibition in Alzheimer's Disease.

  2004cited by this paper
• Dissecting the pathological effects of human Abeta40 and Abeta42 in Drosophila: a potential model for Alzheimer's disease.

  2004cited by this paper
• Dissecting the pathological effects of human Aβ40 and Aβ42 in Drosophila: A potential model for Alzheimer's disease

  2004cited by this paper
• Novel Biginelli-like three-component cyclocondensation reaction: efficient synthesis of 5-unsubstituted 3,4-dihydropyrimidin-2(1H)-ones

  2004cited by this paper
• Specific targeting of acetylcholinesterase and butyrylcholinesterase recognition sites. Rational design of novel, selective, and highly potent cholinesterase inhibitors.

  2003cited by this paper
• Peripheral and dual binding site inhibitors of acetylcholinesterase as neurodegenerative disease modifying agents

  2003cited by this paper
• Cholinesterases: New Roles in Brain Function and in Alzheimer's Disease

  2003cited by this paper
• A Long-Term Comparison of Galantamine and Donepezil in the Treatment of Alzheimer’s Disease

  2003cited by this paper
• The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

  2002cited by this paper
• PDBsum: summaries and analyses of PDB structures

  2001cited by this paper
• Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the Abraham descriptors.

  2001cited by this paper
• Peripheral and dual binding site acetylcholinesterase inhibitors: implications in treatment of Alzheimer's disease.

  2001cited by this paper
• Predicting blood-brain barrier permeation from three-dimensional molecular structure.

  2000cited by this paper
• Design and development of selective muscarinic agonists for the treatment of Alzheimer's disease: characterization of tetrahydropyrimidine derivatives and development of new approaches for improved affinity and selectivity for M1 receptors.

  2000cited by this paper
• The Protein Data Bank and the challenge of structural genomics

  2000cited by this paper
• The Protein Data Bank

  2000cited by this paper
• MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening.

  1999cited by this paper
• The cholinergic hypothesis of Alzheimer’s disease: a review of progress

  1999cited by this paper
• Psychiatry and Paedophilia: A Major Public Health Issue

  1998cited by this paper
• Structure of acetylcholinesterase complexed with the nootropic alkaloid, (–)-huperzine A

  1997cited by this paper
• Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme.

  1996cited by this paper
• The treatment of Alzheimer's disease

  1995cited by this paper
• Cholinesterase inhibitors increase secretion of APPs in rat brain cortex.

  1995cited by this paper
• Normal and abnormal biology of the beta-amyloid precursor protein.

  1994cited by this paper
• Deletion of the donor splice site of intron 4 in the glucokinase gene causes maturity-onset diabetes of the young.

  1993cited by this paper
• Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides.

  1990cited by this paper
• Conformational analysis. 47. Stereochemistry of organic sulfur compounds. 21. Conformation of oxanes with sulfur substituents

  1987cited by this paper
• Chemical graphs

  1979cited by this paper
• Structural determination of paraffin boiling points.

  1947cited by this paper
• Electronic Reprint Biological Crystallography the Protein Data Bank Biological Crystallography the Protein Data Bank

  year unknowncited by this paper

• Spectroscopic and Electronic Structure Analysis of 1-Acetylpiperidine-4-Carboxylic Acid with Molecular Interaction Evaluation

  2026cites this paper
• Synthesis of Thiazole-methylsulfonyl Derivatives, X-ray Study, and Investigation of Their Carbonic Anhydrase Activities: In Vitro and In Silico Potentials

  2025cites this paper
• Chemical design, preparation, agricultural bioefficacy valuation, and molecular docking of some pyridine containing compounds

  2025cites this paper
• Discovery of new acetylcholinesterase inhibitors derived from quinazolinones: synthesis, in vitro, and molecular docking study

  2025cites this paper
• Preparation, Agricultural Bioactivity Evaluation, Structure-Activity Relationships Estimation, and Molecular Docking of Some Quinazoline Compounds.

  2024cites this paper
• Content CN-21-5

  2023cites this paper
• Purinergic Signaling and its Role in the Stem Cell Differentiation.

  2023cites this paper
• A REVIEW OF ROLE OF X-RAY DIFFRACTION IN STRUCTURAL ELUCIDATION OF BIOLOGICAL MOLECULES

  2023cites this paper
• Inhibitory Effects of Cannabinoids on Acetylcholinesterase and Butyrylcholinesterase Enzyme Activities

  2022cites this paper
• Assessing the therapeutic and toxicological profile of novel acetylcholinesterase reactivators: value of in silico and in vitro data.

  2022cites this paper
• Synthesis and In Silico Prediction of Biological Activity and Acute Toxicity of [1,3]Thiazolo[3,2-a]pyrimidines Containing Aliphatic Aldehyde Fragments

  2022cites this paper
• Mitochondrial Medicine: A Promising Therapeutic Option Against Various Neurodegenerative Disorders

  2022cites this paper
• Neuroprotective Effects of the Psychoactive Compound Biatractylolide (BD) in Alzheimer’s Disease

  2022cites this paper
• A Comprehensive Review of Cholinesterase Modeling and Simulation

  2021cites this paper
• Synthesis of new thiazolo[3,2-a]pyrimidine derivatives and in silico analysis of their bioactivity

  2021cites this paper
• Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer's action: Design, synthesis, crystal structure and in-vitro biological evaluation.

  2021cites this paper
• International Journal of Current Microbiology and Applied Sciences

  2020cites this paper
• Design, synthesis and biological activity evaluation of novel carbazole-benzylpiperidine hybrids as potential anti Alzheimer agents

  2020cites this paper
• Ligand-based pharmacophore modelling and virtual screening for the identification of amyloid-beta diagnostic molecules.

  2020cites this paper
• Targeting of Perforin Inhibitor into the Brain Parenchyma Via a Prodrug Approach Can Decrease Oxidative Stress and Neuroinflammation and Improve Cell Survival

  2020influential citation
• Role of mitochondrial dysfunction, oxidative stress and autophagy in progression of Alzheimer's disease.

  2020cites this paper
• Revisiting fish toxicity of active pharmaceutical ingredients: Mechanistic insights from integrated ligand-/structure-based assessments on acetylcholinesterase.

  2019cites this paper
• Design and development of novel N-(pyrimidin-2-yl)-1,3,4-oxadiazole hybrids to treat cognitive dysfunctions.

  2019cites this paper
• Three Novel Mutations I65S, R66S, and G86R Divulge Significant Conformational Variations in the PTB Domain of the IRS1 Gene

  2019cites this paper
• Synthesis of New Heteroaryl α‐Aminophosphonates and Evaluation of Their Cytotoxicity against Human Breast Cancer MCF‐7 Cell Lines

  2018cites this paper
• Exploring molecular structural requirement for AChE inhibition through multi-chemometric and dynamics simulation analyses

  2018cites this paper
• Computer-aided design of temozolomide derivatives based on alkylglycerone phosphate synthase structure with isothiocyanate and their pharmacokinetic/toxicity prediction and anti-tumor activity in vitro

  2018cites this paper
• ADME/toxicity prediction and antitumor activity of novel nitrogenous heterocyclic compounds designed by computer targeting of alkylglycerone phosphate synthase

  2018cites this paper
• Mitochondrial permeability transition pore: a potential drug target for neurodegeneration.

  2018cites this paper
• Pyrimidine‐Triazolopyrimidine and Pyrimidine‐Pyridine Hybrids as Potential Acetylcholinesterase Inhibitors for Alzheimer's Disease

  2018cites this paper
• Environmental relevant levels of the cytotoxic drug cyclophosphamide produce harmful effects in the polychaete Nereis diversicolor.

  2018cites this paper
• Synthesis and Structure of 7-Hydroxy-5-Oxo-2,3-Dihydro-5H-[1,3]Thiazolo[3,2-a]-Pyrimidine-6-Carboxylic Acid Ethyl Ester

  2017cites this paper
• Multitarget compounds bearing tacrine- and donepezil-like structural and functional motifs for the potential treatment of Alzheimer's disease.

  2017cites this paper
• Multitarget Tacrine Hybrids with Neuroprotective Properties to Confront Alzheimer's Disease.

  2017cites this paper
• Mitochondria as a Therapeutic Target for the Treatment of Alzheimer’s Disease

  2017cites this paper
• Identification of molecular descriptors for design of novel Isoalloxazine derivatives as potential Acetylcholinesterase inhibitors against Alzheimer’s disease

  2017cites this paper
• An enantiomer-based virtual screening approach: Discovery of chiral organophosphates as acetyl cholinesterase inhibitors.

  2017cites this paper
• Metformin and Its Sulfenamide Prodrugs Inhibit Human Cholinesterase Activity

  2017cites this paper
• Tacrine, Trolox and Tryptoline as Lead Compounds for the Design and Synthesis of Multi-target Agents for Alzheimer’s Disease Therapy

  2017cites this paper
• Perspectives for the structure-based design of acetylcholinesterase reactivators.

  2016cites this paper
• Novel Therapeutic Strategies for Dementia.

  2016cites this paper
• Unravelling new ethnopharmacological roles of Plectranthus species: biological activity screening

  2016cites this paper
• Rational design and synthesis of dihydropyrimidine based dual binding site acetylcholinesterase inhibitors.

  2016cites this paper
• Design, Synthesis, In Silico and In Vitro Studies of Substituted 1, 2, 3, 4- Tetrahydro Pyrimidine Phosphorus Derivatives.

  2015cites this paper
• Molecular Docking Study on Galantamine Derivatives as Cholinesterase Inhibitors

  2015cites this paper
• Synthesis and Spectral characterization of Pyrimidine analogues: An antimicrobial activity against clinically isolated microbes

  2015cites this paper
• A One-Pot Three Component Green Synthesis of 1-Aminoalkyl-2-Naphthols Using Grindstone Chemistry

  2015cites this paper
• SYNTHESIS, SPECTRAL CHARACTERIZATION AND ANTIMICROBIAL ACTIVITY OF NOVEL UREA/THIOUREA DERIVATIVES

  2015cites this paper
• SYNTHESIS AND CHARACTERIZATION OF NOVEL PHOSPHORYLATED DERIVATES OF ZIDOVUDINE : ANTICANCER ACTIVITY AGAINST HUMAN BREAST CANCER CELL LINES ( MCF 7 )

  2015cites this paper
• Mutations in exons 10 and 11 of human glucokinase result in conformational variations in the active site of the structure contributing to poor substrate binding – explains hyperglycemia in type 2 diabetic patients

  2015cites this paper
• PHOSPHOSULFONIC ACID (PSA) UNDER SOLVENT-FREE CONDITIONS

  2015cites this paper
• Screening and Identification of Inhibitors Against Glutathione Synthetase, A Potential Drug Target of Plasmodium falciparum.

  2015cites this paper
• Synthesis, Spectral Characterization and Anti Bacterial Activity of Novel Thiourea Analogues

  2015cites this paper
• Identification of human presequence protease (hPreP) agonists for the treatment of Alzheimer's disease.

  2014cites this paper
• STRUCTURE BASED PHARMACOPHORE, VIRTUAL SCREENING AND ANTIBACTERIAL ACTIVITY OF NOVEL MOLECULES

  2014influential citation
• Determination of Small Molecule ABAD Inhibitors Crossing Blood-Brain Barrier and Pharmacokinetics

  2014cites this paper
• Pharmacogenomics of Alzheimer's disease: novel therapeutic strategies for drug development.

  2014cites this paper
• High-resolution crystal structures of two crystal forms of human cyclophilin D in complex with PEG 400 molecules.

  2014cites this paper
• Design, synthesis, in silico and in vitro studies of novel 4-methylthiazole-5-carboxylic acid derivatives as potent anti-cancer agents.

  2014cites this paper
• Mitochondrial permeability transition pore is a potential drug target for neurodegeneration.

  2014cites this paper
• Identification of human ABAD inhibitors for rescuing Aβ-mediated mitochondrial dysfunction.

  2014cites this paper
• Structure Based Design, Synthesis, Pharmacophore Modeling, Virtual Screening, and Molecular Docking Studies for Identification of Novel Cyclophilin D Inhibitors

  2014cites this paper
• Structural and Functional analysis of Staphylococcus aureus NADP-dependent IDH and its comparison with Bacterial and Human NADPdependent IDH

  2014cites this paper
• Dual Binding Site and Selective Acetylcholinesterase Inhibitors Derived from Integrated Pharmacophore Models and Sequential Virtual Screening

  2014cites this paper
• Pharmacogenomics in Drug Discovery and Development

  2014cites this paper
• Novel heteroaryl phosphonicdiamides PTPs inhibitors as anti-hyperglycemic agents

  2014cites this paper